These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [A diffusion method to find the antimicrobial sensitivity of Bacteroides fragilis. Comparative study with a plate dilution technic]. de la Torre Misiego F; López Bartolome O; Betriu Cabecerán C; Rodríguez Avial C; Cogollos Agruña R Rev Clin Esp; 1984 Aug 15-31; 174(3-4):103-5. PubMed ID: 6515069 [No Abstract] [Full Text] [Related]
24. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina. Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852 [TBL] [Abstract][Full Text] [Related]
25. Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. Ricci V; Piddock L J Antimicrob Chemother; 2003 Oct; 52(4):605-9. PubMed ID: 12951329 [TBL] [Abstract][Full Text] [Related]
26. Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods. Hastey CJ; Dale SE; Nary J; Citron D; Law JH; Roe-Carpenter DE; Chesnel L Anaerobe; 2017 Apr; 44():73-77. PubMed ID: 28188880 [TBL] [Abstract][Full Text] [Related]
27. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance. Tierney D; Copsey SD; Morris T; Perry JD Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277 [TBL] [Abstract][Full Text] [Related]
28. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040 [TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods. Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346 [TBL] [Abstract][Full Text] [Related]
30. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility. Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of diffusion and dilution methods to determine the antimicrobial activity of water-soluble chitosan derivatives. Jiang L; Wang F; Han F; Prinyawiwatkul W; No HK; Ge B J Appl Microbiol; 2013 Apr; 114(4):956-63. PubMed ID: 23279192 [TBL] [Abstract][Full Text] [Related]
32. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents. Niederau W; Höffler U; Pulverer G Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of agar dilution and broth microdilution methods for antibiotic susceptibility testing of Helicobacter cinaedi. Tomida J; Oumi A; Okamoto T; Morita Y; Okayama A; Misawa N; Hayashi T; Akaike T; Kawamura Y Microbiol Immunol; 2013 May; 57(5):353-8. PubMed ID: 23668607 [TBL] [Abstract][Full Text] [Related]
35. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms. Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287 [TBL] [Abstract][Full Text] [Related]
37. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis. Weber P; Dubois S; Boussougant Y J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487 [TBL] [Abstract][Full Text] [Related]
38. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria. Aldridge KE Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509 [TBL] [Abstract][Full Text] [Related]
39. Discrepant behaviour of clotrimazole against Bacteroides fragilis in liquid and solid media. Reynolds AV; Hamilton-Miller JM; Brumfitt W J Antimicrob Chemother; 1977 Nov; 3(6):622-4. PubMed ID: 599124 [No Abstract] [Full Text] [Related]
40. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics. Bansal MB; Chuah SK; Thadepalli H Chemotherapy; 1984; 30(4):237-43. PubMed ID: 6744975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]